leadf
logo-loader
viewParallax Health Sciences Inc.

Parallax Health Sciences CEO outlines 2019 goals for tele-health services business

Parallax Health Sciences Inc (OTCMKTS:PRLX) CEO Paul Arena tells Proactive Investors timing is everything for the data-driven connected healthcare company, as he says the company is gearing up to launch its remote patient monitoring platform over the next 3 months.

Arena says the company is raising $6 million to expand the business within the US and internationally.

Quick facts: Parallax Health Sciences Inc.

Price: 0.011 USD

OTCQB:PRLX
Market: OTCQB
Market Cap: $2.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Parallax Health Sciences Inc. named herein, including the promotion by the Company of Parallax Health Sciences Inc. in any Content on the Site,...

FOR OUR FULL DISCLAIMER CLICK HERE

Full interview: Parallax Health Sciences on an 'accelerated path' in its...

Parallax Health Sciences Inc (OTCMKTS:PRLX) Chief Technology Office Nathaniel Bradley tells Proactive its subsidiary Parallax Diagnostics Inc is distributing vitamin D supplements to coronavirus medical and clinical services workers through a partnership with CURE Pharmaceutical Holding...

on 04/07/2020

2 min read